<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-045117</identifier>
<setSpec>1130-5665</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Modulatory effects of phytoestrogens on human osteoblast cell differentiation</dc:title>
<dc:description xml:lang="en">Estrogens, the main factors responsible for the maintenanceof bone mass in women, inhibit bone resorption at leastin part by interacting with osteoblasts. Plant isoflavoneshave estrogen-like features and thus a potential role in preventingosteoporosis. In the present study, the effects of genistein,daidzein and resveratrol on several osteoblastic markerswere evaluated. We found that these phytoestrogens,similarly to 17b-oestradiol, failed to affect Cbfa1/runx2transcription factor activity and the PTH1 receptor proteinexpression (early osteoblast differentiation markers) in eitherosteoblastic cells from human trabecular bone or humanosteoblastic osteosarcoma cells MG-63. In contrast, inthe latter cells, these agents increased alkaline phosphataseactivity, as well as osteocalcin and osteoprotegerin expression,but they decreased NF-kB-dependent interleukin-6mRNA expression. Meanwhile, they differently affect theprotein expression of the receptor activator of NF-kB ligand.Our findings indicate that these phytoestrogens display osteogenicactions which appear to be mediated through estrogenicreceptors in human osteoblasts</dc:description>
<dc:creator>Esbrit Argüelles, P</dc:creator>
<dc:creator>Alonso Rodríguez, V</dc:creator>
<dc:creator>Gortázar, A. R. de</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Los estrógenos, principales responsables del mantenimientode la masa ósea en la mujer, inhiben la resorción óseaen parte a través de su interacción con los osteoblastos. Losisoflavonoides vegetales poseen propiedades estrogénicas y unpotencial terapéutico en la osteoporosis. En el estudio planteado,se han evaluado los efectos de la genisteína, daidzeína yresveratrol sobre la función osteoblástica. Estos fitoestrógenos,de modo similar al b-estradiol, no afectan a la actividaddel factor de transcripción cbfa1/runx2 ni la expresión proteicadel receptor PTH1 (marcadores precoces de diferenciaciónosteoblástica) en células osteoblásticas de hueso trabecularhumano o en células MG-63 de osteosarcoma humano. Sinembargo, en estas células, estos agentes estimularon la actividadde fosfatasa alcalina, y la expresión de osteocalcina y deosteoprotegerina, e inhibieron la interleuquina-6 a través delfactor NF-kB; mientras que ejercieron efectos variables sobrela expresión proteica del ligando del receptor activador delNF-kB. Nuestros resultados indican que los fitoestrógenosanalizados poseen acciones osteoformadoras mediadas por receptoresestrogénicos en los osteoblastos humanos</dc:description>
<dc:source>MAPFRE med;16(3): 174-183, jul. 2005. ilus</dc:source>
<dc:identifier>ibc-045117</dc:identifier>
<dc:title xml:lang="es">Efectos moduladores de los fitoestrogenos sobre la diferenciacion de osteoblastos humanos</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d2489^s22021</dc:subject>
<dc:subject>^d24820^s22063</dc:subject>
<dc:subject>^d29472^s22063</dc:subject>
<dc:subject>^d5060^s22079</dc:subject>
<dc:subject>^d24823^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13406</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d10184^s22021</dc:subject>
<dc:subject>^d24016^s22002</dc:subject>
<dc:subject>^d10191^s22021</dc:subject>
<dc:subject>^d471^s22063</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d33414^s22079</dc:subject>
<dc:subject>^d30227^s22021</dc:subject>
<dc:type>article</dc:type>
<dc:date>200507</dc:date>
</metadata>
</record>
</ibecs-document>
